Julia Wang A.'s most recent trade in Laboratory Corp. Of America Holdings was a trade of 7,800 Non-qualified Stock Options done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Julia Wang A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 7,800 | 7,800 | - | - | Non-qualified Stock Options | |
| Labcorp | Julia Wang A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,580 | 4,367 | - | - | Restricted Stock Unit | |
| Labcorp | Julia Wang A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 893 | 893 (0%) | 0% | - | Common Stock | |
| Labcorp | Julia Wang A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 893 | 1,787 | - | - | Restricted Stock Unit | |
| Labcorp | Julia Wang A. | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 336 | 557 (0%) | 0% | 247.7 | 83,241 | Common Stock |